Fig. 3.
Fig. 3. MRC-10 Study. Leukemia-free survival of patients randomized to ABMT or STOP arm. (Reprinted with permission from Burnett et al, “Randomized comparison of autologous bone marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: Results of MRC-AML 10 trial,” volume 351, page 705. © by The Lancet Ltd, 1998.163)

MRC-10 Study. Leukemia-free survival of patients randomized to ABMT or STOP arm. (Reprinted with permission from Burnett et al, “Randomized comparison of autologous bone marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: Results of MRC-AML 10 trial,” volume 351, page 705. © by The Lancet Ltd, 1998.163)

Close Modal

or Create an Account

Close Modal
Close Modal